Skip to main content
SpringerLink
Log in

Late-breaking trials at the ACC scientific sessions: Insights and controversy

  • Editor’s Commentary
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kastelein JJ, Akdim F, Stroes ES, et al.: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 358:1431–1443.

    Article  PubMed  CAS  Google Scholar 

  2. Drazen JM, Jarcho JA, Morrissey S, Curfman GD: Cholesterol lowering and ezetimibe. N Engl J Med 2008, 358:1507–1508.

    Article  PubMed  CAS  Google Scholar 

  3. Brown BG, Taylor AJ: Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? N Engl J Med 2008, 358:1504–1507.

    Article  PubMed  CAS  Google Scholar 

  4. Berenson, A: After a Trial, Silence. New York Times. November 21, 2007. http://query.nytimes.com/gst/fullpage.html?res=950CE6DC1330F932A15752C1A9619C8B63&fta=y.

  5. The Speech That Maimed Schering And Merck. Forbes. April 3, 2008. http://www.forbes.com/business/pharma/2008/04/03/vytorin-merck-schering-biz-healthcarecx_mh_0402schering.html.

  6. The ONTARGET Investigators: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 Mar 31 (Epub ahead of print).

  7. Nissen SE, Nicholls SJ, Wolski K, et al.: Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 2008, 299:1561–1573.

    Article  PubMed  CAS  Google Scholar 

  8. Beckett NS, Peters R, Fletcher AE, et al.: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008 Mar 31 (Epub ahead of print.)

  9. Nissen SE, Nicholls SJ, Wolski K, et al.: Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA 2008, 299:1547–1560.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, The Cleveland Clinic, 9500 Euclid Avenue, Desk F25, Cleveland, OH, 44195, USA

    Steven E. Nissen

Authors
  1. Steven E. Nissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven E. Nissen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nissen, S.E. Late-breaking trials at the ACC scientific sessions: Insights and controversy. Curr Cardiol Rep 10, 247–249 (2008). https://doi.org/10.1007/s11886-008-0041-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-008-0041-1

Search

Navigation